NEA supports Pathos AI Series E raise
The firm continues backing the healthtech company as it utilizes AI agents to accelerate drug development and improve clinical trial success rates.
See the latest news and media coverage for NEA. We track all announcements, press releases, and industry mentions in real time, all in one place.
Venture capital firm
nea.comLast updated
In short: NEA led major AI funding rounds, launched healthcare ventures, and received $100M from Japan's JIC.
The firm continues backing the healthtech company as it utilizes AI agents to accelerate drug development and improve clinical trial success rates.
The firm views Spiko as the only company solving regulatory and product challenges for universal yield, establishing a new default home for cash.
Scott Sandell becomes Executive Chairman and CIO. The firm emphasizes succession planning and continuous evolution in leadership.
The funds target technology and healthcare investments across stages and sectors, marking the largest capital pool in NEA's history as of January 26, 2023.
Japan Investment Corporation (JIC) has invested US$100 million in two funds managed by US venture capital firm New Enterprise Associates (NEA) in a move to...
NEA 17 fund reports a sizable net share and warrant purchase in Korro Bio. The reporting structure shows that New Enterprise Associates 17, L.P. acquired...
Union.ai today announced it has ... by New Enterprise Associates (NEA), with participation from Nava Ventures and new investor Mozilla Ventures. The total includes the...
New Enterprise Associates reports beneficial ownership of 7,392,301 SpyGlass Pharma common shares, or 22.2% of the company. This percentage is based on 33,317,414 shares outstanding...
Track NEA and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to NEA and other trending companies.